The effects of succimer chelation therapy on auditory function in rhesus monkeys

Neurotoxicology and Teratology

Volumn 23, Issue 6, 2001, Pages 651-658

  Lasky, Robert E ^a   Luck, Melissa L ^b   Laughlin, Nellie K ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Auditory evoked potentials; Distortion product otoacoustic emissions; Lead; Rhesus monkey; Succimer; Tympanometry

Indexed keywords

SUCCIMER;

ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; BRAIN STEM; CHELATION THERAPY; COCHLEA; COCHLEAR NERVE; CONTROLLED STUDY; DISTORTION PRODUCT OTOACOUSTIC EMISSION; DRUG BLOOD LEVEL; EVOKED AUDITORY RESPONSE; FEMALE; HEARING; LEAD POISONING; MIDDLE EAR; NEWBORN; NONHUMAN; OTOACOUSTIC EMISSION; PRIORITY JOURNAL; RHESUS MONKEY; TYMPANOMETRY;

ACOUSTIC IMPEDANCE TESTS; ANIMALS; AUDITORY THRESHOLD; CHELATING AGENTS; EVOKED POTENTIALS, AUDITORY; FEMALE; LEAD POISONING; MACACA MULATTA; SUCCIMER;

MACACA MULATTA;

EID: 0035711814     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0892-0362(01)00176-3     Document Type: Article

References (32)

1. Meso-2,3-dimercaptosuccinic acid: Chemical, pharmacological and toxicological properties of an orally effective metal chelating agent
2. Recovery of slowed nerve conduction velocity in lead-exposed workers
3. BAL, EDTA, DMSA and DMPS in the treatment of lead poisoning in children
4. Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure
5. 2,3-Dimercaptosuccinic acid treatment of heavy metal poisoning in humans
6. Management of childhood lead poisoning: Strategies for chelation
7. Role of chelating agents for prevention, intervention and treatment of exposure to toxic metals
8. Role of 2,3-dimercaptosuccinic acid in the treatment of heavy metal poisoning
9. 2,3-Dimercaptosuccinic acid: A new agent for the treatment of lead poisoning
10. Hearing loss related to zinc deficiency in rats
11. The effects of elevated blood lead levels and succimer chelation therapy on physical growth in developing rhesus monkeys
12. The effects of early lead exposure on auditory function in rhesus monkeys
13. Distortion product otoacoustic emissions in human newborns and adults
14. Otoacoustic emission, evoked potential, and behavioral auditory thresholds in the rhesus monkey (Macaca mulatta)
15. Oral chelators for childhood lead poisoning
16. Perinatal iron deficiency and the developing brain
17. Changes in the uptake of lead over weaning in infant rhesus monkeys
18. Assessment of central, peripheral, and autonomic nervous system functions in lead workers: Neuroelectrophysiological studies
19. Succimer (DMSA) approved for severe lead poisoning
20. Absolute auditory thresholds in three old world monkey species (Cercopithecus aethiops, C. neglectus, Macaca fuscata) and humans (Homo sapiens)
21. Reaction-time procedure for measurement of hearing: II. Threshold functions
22. Pure tone thresholds for the rhesus monkey
23. The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead
24. Evidence of altered central nervous system development in infants with iron deficiency anemia at 6 mo: Delayed maturation of auditory brainstem responses
25. The new CDC and AAP lead poisoning prevention recommendations: Consensus versus controversy
26. 204Pb
27. Auditory sensitivity of the monkey
28. The Treatment of Lead-Exposed Children (TLC) Trial: Design and recruitment for a study of the effect of oral chelation on growth and development in toddlers
29. Safety and efficacy of succimer in toddlers with blood lead levels of 20-44 mcg/dL
30. Comparative mobilization of lead by chelating agents